Cargando…

Effect of Phentermine on Hepatic Steatosis in Bariatric Surgery: A Pilot Study

OBJECTIVE: Hepatic steatosis is associated with increased surgical complications in bariatric surgery patients. We aimed to evaluate the effect of phentermine in reducing hepatic steatosis, adipose tissue, and surgical complications in patients undergoing bariatric surgery. METHODS: This was a two-a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pérez-Cruz, Elizabeth, Guevara-Cruz, Martha, Ortiz-Gutiérrez, Salvador, Luna-Camacho, Yuritzy, Guzmán-Aguilar, Rafael, Briceño-Sáenz, Giuseppe, González-Salazar, Luis, Flores-López, Adriana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2022
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275005/ https://www.ncbi.nlm.nih.gov/pubmed/35526530 http://dx.doi.org/10.1159/000524805

Ejemplares similares

Effect of the Melanocortin 4-Receptor Ile269Asn Mutation on Weight Loss Response to Dietary, Phentermine and Bariatric Surgery Interventions
por: Salazar-Valencia, Itzel G., et al.
Publicado: (2022)

Impact of obesity and diabetes mellitus in critically ill patients with SARS-CoV-2
por: Pérez-Cruz, Elizabeth, et al.
Publicado: (2021)

Phentermine, Sibutramine and Affective Disorders
por: An, Hoyoung, et al.
Publicado: (2013)

Three- and six-month efficacy and safety of phentermine in a Mexican obese population
por: Márquez-Cruz, Maribel, et al.
Publicado: (2021)

Pulmonary Hypertension Associated with Use of Phentermine
por: Bang, Woo-Dae, et al.
Publicado: (2010)

RE: Pulmonary Hypertension Associated with Use of Phentermine?
por: Hendricks, Ed J., et al.
Publicado: (2011)

Phentermine and topiramate for the management of obesity: a review
por: Cosentino, Gina, et al.
Publicado: (2011)

Phentermine-topiramate: First combination drug for obesity
por: Singh, Jagjit, et al.
Publicado: (2015)

The Use of Phentermine for Obesity in Psychiatric Patients With Antipsychotics
por: Kim, Eunju, et al.
Publicado: (2023)

Coadministration of lorcaserin and phentermine for weight management: A 12‐week, randomized, pilot safety study
por: Smith, Steven R., et al.
Publicado: (2017)

Cardiovascular Safety During and After Use of Phentermine and Topiramate
por: Ritchey, Mary E, et al.
Publicado: (2018)

Takotsubo Cardiomyopathy Due to Combined Use of Phentermine and Lisdexamfetamine
por: Burleigh, Tara, et al.
Publicado: (2020)

A Rare Case of Phentermine-Induced Nonischemic Cardiomyopathy
por: Damani, Devanshi, et al.
Publicado: (2022)

Obesity pillars roundtable: Phentermine – Past, present, and future
por: Bays, Harold Edward, et al.
Publicado: (2022)

Weight Loss at First Month and Development of Tolerance as Possible Predictors of 30 mg Phentermine Efficacy at 6 Months
por: Rocha-González, Héctor Isaac, et al.
Publicado: (2021)

Effects of Orlistat/Phentermine versus Phentermine on Vascular Endothelial Cell Function in Obese and Overweight Adults: A Randomized, Double-Blinded, Placebo-Controlled Trial
por: Kwon, Yu-Jin, et al.
Publicado: (2021)

Clinical utility of phentermine/topiramate (Qsymia™) combination for the treatment of obesity
por: Shin, Jin Hee, et al.
Publicado: (2013)

Postmarketing Surveillance Study of the Efficacy and Safety of Phentermine in Patients with Obesity
por: Kim, Hyun Ok, et al.
Publicado: (2013)

Abstract: Phentermine: A Systematic Review for Plastic & Reconstructive Surgeons
por: Lim, Soobin, et al.
Publicado: (2018)

A Narrative Review: Phentermine and Topiramate for the Treatment of Pediatric Obesity
por: Kim, Anthony, et al.
Publicado: (2023)

Management of obesity and cardiometabolic risk – role of phentermine/extended release topiramate
por: Sweeting, Arianne N, et al.
Publicado: (2014)

Combination of venlafaxine and phentermine/topiramate induced psychosis: A case report
por: Homola, Jaclyn, et al.
Publicado: (2018)

MON-095 Phentermine Induces Weight Loss in Prader-Willi Syndrome
por: Mottalib, Adham, et al.
Publicado: (2019)

Phentermine Use During First and Second Trimesters Associated with Fetal Stroke
por: D'Adesky, Nathan, et al.
Publicado: (2019)

Phentermine-Associated Atrial Fibrillation: A Case Report and Literature Review
por: Manasrah, Nouraldeen, et al.
Publicado: (2022)

Positive Regadenoson Stress Test in a Patient on Phentermine With Normal Coronaries
por: Sendil, Selin, et al.
Publicado: (2022)

Lorcaserin and phentermine exert anti-obesity effects with modulation of the gut microbiota
por: Song, Eun-Ji, et al.
Publicado: (2023)

Cardiovascular effects of phentermine and topiramate: a new drug combination for the treatment of obesity
por: Jordan, Jens, et al.
Publicado: (2014)

Greater hunger and less restraint predict weight loss success with phentermine treatment
por: Thomas, Elizabeth A., et al.
Publicado: (2015)

Formulary Management of 2 New Agents: Lorcaserin and Phentermine/Topiramate for Weight Loss
por: Kelly, Elizabeth M., et al.
Publicado: (2013)

A case of phentermine-induced psychosis: the need for caution for drug-drug interactions
por: Sreevalsam Anil, S., et al.
Publicado: (2023)

Effects on Weight Reduction and Safety of Short-Term Phentermine Administration in Korean Obese People
por: Kim, Kyoung Kon, et al.
Publicado: (2006)

Recurrent Psychosis after Phentermine Administration in a Young Female: A Case Report
por: Jo, Hyun-Sic, et al.
Publicado: (2019)

Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)
por: Allison, David B., et al.
Publicado: (2012)

Effects of anti-obesity drugs, phentermine and mahuang, on the behavioral patterns in Sprague-Dawley rat model
por: Go, Ryeo-Eun, et al.
Publicado: (2014)

Improvement of hepatic steatosis and fibrosis in diabetes: Which bariatric procedure is more appropriate?
por: Jia, Weiping
Publicado: (2022)

Effect of guanylin peptides on pancreas steatosis and function in experimental diet-induced obesity and after bariatric surgery
por: Otero, Aarón, et al.
Publicado: (2023)

Prevention of Type 2 Diabetes in Subjects With Prediabetes and Metabolic Syndrome Treated With Phentermine and Topiramate Extended Release
por: Garvey, W. Timothy, et al.
Publicado: (2014)

Investigating interactions between phentermine, dexfenfluramine, and 5-HT(2C) agonists, on food intake in the rat
por: Grottick, Andrew J., et al.
Publicado: (2014)

The Triple Combination Phentermine Plus 5-HTP/Carbidopa Leads to Greater Weight Loss, With Fewer Psychomotor Side Effects Than Each Drug Alone
por: Perez, Claudia I., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_flrtrvadpnblfq1319gi77r2mb